1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors

Details for Australian Patent Application No. 2003250232 (hide)

International Classifications

Event Publications

16 October 2003 Complete Application Filed

Priority application(s): 02077310.7 30.05.02 EP

12 February 2004 Application Open to Public Inspection

Published as AU-B-2003250232

21 August 2008 Alteration of Name

The name of the applicant has been altered to Solvay Pharmaceuticals B.V.; Arqule, Inc 2004

11 September 2008 Application Accepted

Published as AU-B-2003250232

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.